These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38878613)

  • 1. ETV4 promotes the progression of cholangiocarcinoma by regulating glycolysis via the TGF-β signaling.
    Liu F; Wang Q; Wang Z; Zhang S; Ni Q; Chang H
    Transl Oncol; 2024 Sep; 47():102035. PubMed ID: 38878613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‑mesenchymal transition in intrahepatic cholangiocarcinoma cells.
    Liu L; Feng Y; Xiang X; Xu M; Tang G
    Oncol Lett; 2024 Aug; 28(2):346. PubMed ID: 38872859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.
    Singsuksawat E; Thuwajit C; Charngkaew K; Thuwajit P
    Cancer Cell Int; 2018; 18():25. PubMed ID: 29467595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TGF-β/Smad
    Yu ZL; Liu J; Ning ZK; Tian HK; Wu X; Huang YF; Wu ZC; Zong Z; Zhou TC
    Mol Carcinog; 2023 Feb; 62(2):261-276. PubMed ID: 36345938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells.
    Sritananuwat P; Sueangoen N; Thummarati P; Islam K; Suthiphongchai T
    Cancer Cell Int; 2017; 17():85. PubMed ID: 28959141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.
    Zhang J; Pan L; Zhang S; Yang Y; Liang J; Ma S; Wu Q
    Clin Transl Oncol; 2023 Dec; 25(12):3527-3540. PubMed ID: 37249759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV4 facilitates proliferation, migration, and invasion of liver cancer by mediating TGF-β signal transduction through activation of B3GNT3.
    Zhou Z; Wu B; Chen J; Shen Y; Wang J; Chen X; Fei F; Li L
    Genes Genomics; 2023 Nov; 45(11):1433-1443. PubMed ID: 37523127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated ETV4 inhibits the proliferation, migration, and invasion of trophoblast cells in preeclampsia.
    Jie Q; Chen L; Liang J; Yang X; Sun F; Ma Y
    Reproduction; 2023 Apr; 165(4):373-381. PubMed ID: 36716247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin C as an effective anti-cancer agent: unveiling its potential role against cholangiocarcinoma and mechanistic insights.
    Chen W; Liu Q; Huang Z; Le C; Wang Y; Yang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13123-13136. PubMed ID: 37474681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
    Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
    Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1.
    Sun D; Li F; Liu L; Yu S; Wang H; Gao X; Liu G; Zhao Y; Qiu G; Jiang X
    Aging (Albany NY); 2022 Jan; 14(1):509-525. PubMed ID: 35022330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B.
    Chen T; Lei S; Zeng Z; Pan S; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
    Int J Mol Med; 2020 Mar; 45(3):886-896. PubMed ID: 31985024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling.
    Zhu T; Zheng J; Zhuo W; Pan P; Li M; Zhang W; Zhou H; Gao Y; Li X; Liu Z
    Cell Death Discov; 2021 May; 7(1):126. PubMed ID: 34052833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.